Combination of CTLA-4 and PD-1 blockers for treatment of cancer

Targeting checkpoints of immune cell activation has been demonstrated to be the most effective approach for activation of anti-tumor immune responses. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and p...

Source: Journal of Experimental and Clinical Cancer Research - June 13, 2019 Category: Cancer & Oncology Authors: Anand Rotte Tags: Review Source Type: research